| 20-03-02 | Dermira : Form 15-12B - Securities Registration Termination | PU |
| 20-02-20 | Dermira : SEC Filing - S-8 POS | PU |
| 20-02-20 | Dermira : SEC Filing - POS AM | PU |
| 20-02-20 | Dermira : Lilly Completes Acquisition of Dermira | PR |
| 20-02-11 | Dermira : Amended tender offer statement by Third Party | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Thompson
PSD | President | - | - |
Carly Loeb
COO | Chief Operating Officer | - | 2017-12-31 |
Gary Thompson
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gordon Brooks
BRD | Director/Board Member | - | 2020-02-19 |
Philip Johnson
BRD | Director/Board Member | 62 | 2020-02-19 |
Michael Thompson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/20/20 | Don | Chief Medical Officer; Director | 562,325 | 1.0281% | ||
| 2/20/20 | Issuer sale | Director | 68,377 | 0.1250% | ||
| 2/20/20 | Issuer sale | Chief Financial Officer | 496,361 | 0.9075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.11% | - | - | 1.03B | |
| -3.00% | +2.27% | +73.26% | +109.90% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.82% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.86% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +480.92% | 27.47B | |
| +2.74% | +12.98% | +54.92% | +25.77% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -15.31% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| +0.94% | +3.36% | +15.30% | +548.19% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +151.77% | 13.4B | |
| Average | +1.13% | +8.36% | +59.09% | +197.68% | 32.17B | |
| Weighted average by Cap. | +0.74% | +9.48% | +58.02% | +157.86% |
Employees
-
